Case report: cannabidiol-induced skin rash: a case series and key recommendations (2022)
- Authors:
- Souza, José Diogo dos Santos
- Fassoni-Ribeiro, Maíra
- Batista, Rayssa Miranda
- Ushirohira, Juliana Mayumi
- Zuardi, Antonio Waldo
- Guimarães, Francisco Silveira
- Campos, Alline Cristina de
- Osório, Flávia de Lima
- Elias, Daniel
- Souza, Cacilda da Silva
- Fassoni, Andréa Aparecida
- Hallak, Jaime Eduardo Cecilio
- Crippa, José Alexandre de Souza
- USP affiliated authors: ZUARDI, ANTONIO WALDO - FMRP ; GUIMARÃES, FRANCISCO SILVEIRA - FMRP ; CAMPOS, ALLINE CRISTINA DE - FMRP ; OSORIO, FLAVIA DE LIMA - FMRP ; SOUZA, CACILDA DA SILVA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; SOUZA, JOSÉ DIOGO DOS SANTOS - FMRP
- Unidade: FMRP
- DOI: 10.3389/fphar.2022.881617
- Subjects: CANABINOIDES; INTERAÇÃO DE MEDICAMENTOS; FERIMENTOS E LESÕES
- Keywords: Cannabidiol; Drug interaction; Side effects; Skin rash; Case report; Case series
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 13, art. 881617, p. 1-6, 2022
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
SOUZA, José Diogo dos Santos et al. Case report: cannabidiol-induced skin rash: a case series and key recommendations. Frontiers in Pharmacology, v. 13, p. 1-6, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.881617. Acesso em: 25 abr. 2025. -
APA
Souza, J. D. dos S., Fassoni-Ribeiro, M., Batista, R. M., Ushirohira, J. M., Zuardi, A. W., Guimarães, F. S., et al. (2022). Case report: cannabidiol-induced skin rash: a case series and key recommendations. Frontiers in Pharmacology, 13, 1-6. doi:10.3389/fphar.2022.881617 -
NLM
Souza JD dos S, Fassoni-Ribeiro M, Batista RM, Ushirohira JM, Zuardi AW, Guimarães FS, Campos AC de, Osório F de L, Elias D, Souza C da S, Fassoni AA, Hallak JEC, Crippa JA de S. Case report: cannabidiol-induced skin rash: a case series and key recommendations [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-6.[citado 2025 abr. 25 ] Available from: https://doi.org/10.3389/fphar.2022.881617 -
Vancouver
Souza JD dos S, Fassoni-Ribeiro M, Batista RM, Ushirohira JM, Zuardi AW, Guimarães FS, Campos AC de, Osório F de L, Elias D, Souza C da S, Fassoni AA, Hallak JEC, Crippa JA de S. Case report: cannabidiol-induced skin rash: a case series and key recommendations [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-6.[citado 2025 abr. 25 ] Available from: https://doi.org/10.3389/fphar.2022.881617 - Cannabidiol as a treatment for mental health outcomes among health care workers during the coronavirus disease pandemic. [Carta]
- Cannabinoids for the treatment of mental disorders [Carta]
- The anxiolytic effects of cannabidiol (CBD)
- Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age
- Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes
- Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial]
- Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
- Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia
- Cannabidiol, a cannabis sativa constituent, as an antipsycholic drug
- Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder
Informações sobre o DOI: 10.3389/fphar.2022.881617 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003113936.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
